miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer

One of the hallmarks of cancer is sustained angiogenesis. Favorable results have been reported in some breast cancer (BC) patients receiving antiangiogenic therapy with bevacizumab (Bev) in combination with chemotherapy, and further knowledge on how Bev can be optimally combined with conventional tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindholm, Evita Maria, Ragle Aure, Miriam, Haugen, Mads Haugland, Kleivi Sahlberg, Kristine, Kristensen, Vessela N., Nebdal, Daniel, Børresen‐Dale, Anne‐Lise, Lingjærde, Ole Christian, Engebraaten, Olav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763780/
https://www.ncbi.nlm.nih.gov/pubmed/31402562
http://dx.doi.org/10.1002/1878-0261.12561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763780/
https://www.ncbi.nlm.nih.gov/pubmed/31402562
http://dx.doi.org/10.1002/1878-0261.12561

Ejemplares similares